Welcome to our book review site go-pdf.online!
You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Transforming Big Pharma
In Transforming Big Pharma John Ansell addresses critically how strategy works in the pharmaceutical industry. The long-standing dearth of new products has led to a growing shortfall in revenues. Ansell assesses the wide range of alternative strategies big pharma companies have been pursuing in recent years in attempting to overcome this. He shows that there is sound evidence to expect the recent upturn in the number of new products reaching the market to go on to greater heights. Chapters assess the complex trends in attrition rates, show how rife spectacular sales underestimation in the industry remains, and explain how conventional wisdom on the chances of product profitability also serio...
Paying for Long-term Care
Projects future patterns of demand and supply and costs a range of options for funding long-term care.
Fundamentals of Market Access for Pharmaceuticals
”Because at the heart of the apparent conflict between public health concerns and capitalistic interests, market access for pharmaceuticals is largely driven by political considerations, the difference with usual consumer goods being that pharmaceuticals are saving lives or years of life in good health”. If pharmaceutical companies are to innovate, they must be incentivised with prices that reflect the value of their products, and the resources and risks involved in their production. To ensure appropriate access to new drugs and treatments for patients in need around the world, affordability is key. How do we tackle this dilemma? This question is critical for all stakeholders. The develo...
Private Equity
During the past few decades, private equity (PE) has attracted considerable attention from investors, practitioners, and academicians. In fact, a substantial literature on PE has emerged. PE offers benefits for institutional and private wealth management clients including diversification and enhancement of risk-adjusted returns. However, several factors such as liquidity concerns, regulatory restrictions, and the lack of transparency limit the attractiveness of some PE options to investors. The latest volume in the Financial Markets and Investments Series, Private Equity: Opportunities and Risks offers a synthesis of the theoretical and empirical literature on PE in both emerging and develop...
Contemporary Issues in Pharmaceutical Patent Law
This collection reflects on contemporary and contentious issues in international rulemaking in regards to pharmaceutical patent law. With chapters from both well-established and rising scholars, the collection contributes to the understanding of the regulatory framework governing pharmaceutical patents as an integrated discipline through the assessment of relevant laws, trends and policy options. Focusing on patent law and related pharmaceutical regulations, the collection addresses the pressing issues governments face in an attempt to resolve policy dilemmas involving competing interests, needs and objectives. The common theme running throughout the collection is the need for policy and law makers to think and act in a systemic manner and to be more reflective and responsive in finding new solutions within and outside the patent system to the long-standing problems as well as emerging challenges
Corporate Governance and Finance Law
Corporate Governance and Finance Law is designed to educate students, researchers, and practitioners on the legal aspects of corporate financial markets within the United States, the Eurozone, and China.
China's Influence on Non-Trade Concerns in International Economic Law
This volume examines the range of Non-Trade Concerns (NTCs) that may conflict with international economic rules and proposes ways to protect them within international law and international economic law. Globalization without local concerns can endanger relevant issues such as good governance, human rights, right to water, right to food, social, economic, cultural and environmental rights, labor rights, access to knowledge, public health, social welfare, consumer interests and animal welfare, climate change, energy, environmental protection and sustainable development, product safety, food safety and security. Focusing on China, the book shows the current trends of Chinese law and policy towa...
Christian Ethics and Biomedical Innovation
In Christian Ethics and Biomedical Innovation, Stephen Goundrey-Smith outlines a strategy for future adoption of human enhancement technologies which will ensure that such technologies are a common good, a strategy which is appropriate for a pluralistic society, yet consistent with Christian ethical principles. Drawing on the history of biomedical innovation to date in pharmaceutical medicine, he argues that technological capability alone is not enough, and that the responsible adoption of enhancement technologies will require active ethical deliberation and robust public policy discourse. Goundrey-Smith argues that biomedical technology, ethics, and public policy together form an essential triad for appropriate future enhancement technology adoption. This approach helps to ensure that biomedical technologies introduced will be common goods, and to reduce the risk of their instrumental use. The use of any technology is closely linked to its sociopolitical and cultural context and, drawing on Augustine’s The City of God, Goundrey-Smith presents a theological vision for good biomedical technology innovation in human society.
WIPO Magazine
None
